Tomoko Nii‐Kono

1.0k total citations
12 papers, 804 citations indexed

About

Tomoko Nii‐Kono is a scholar working on Nephrology, Genetics and Molecular Biology. According to data from OpenAlex, Tomoko Nii‐Kono has authored 12 papers receiving a total of 804 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Nephrology, 4 papers in Genetics and 3 papers in Molecular Biology. Recurrent topics in Tomoko Nii‐Kono's work include Parathyroid Disorders and Treatments (9 papers), Genetic Syndromes and Imprinting (4 papers) and Pharmacological Effects and Toxicity Studies (3 papers). Tomoko Nii‐Kono is often cited by papers focused on Parathyroid Disorders and Treatments (9 papers), Genetic Syndromes and Imprinting (4 papers) and Pharmacological Effects and Toxicity Studies (3 papers). Tomoko Nii‐Kono collaborates with scholars based in Japan, United States and China. Tomoko Nii‐Kono's co-authors include Masafumi Fukagawa, Hideyuki Yamato, Junichiro James Kazama, Masaru Motojima, Takashi Shigematsu, Ayako Fujieda, Kiyoshi Kurokawa, Seiji Fukumoto, Shohei Nakanishi and Takeyoshi Yamashita and has published in prestigious journals such as Kidney International, Nephrology Dialysis Transplantation and Current Opinion in Nephrology & Hypertension.

In The Last Decade

Tomoko Nii‐Kono

12 papers receiving 787 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomoko Nii‐Kono Japan 10 693 240 230 211 134 12 804
Fabiana G. Graciolli Brazil 12 792 1.1× 298 1.2× 219 1.0× 225 1.1× 111 0.8× 19 896
Laura C. McCary United States 8 804 1.2× 317 1.3× 174 0.8× 388 1.8× 73 0.5× 11 1.0k
Arnold J. Felsenfeld United States 9 614 0.9× 189 0.8× 158 0.7× 179 0.8× 63 0.5× 10 681
Pablo Román‐García Spain 14 471 0.7× 146 0.6× 142 0.6× 138 0.7× 149 1.1× 19 700
Kátia R. Neves Brazil 12 991 1.4× 329 1.4× 181 0.8× 263 1.2× 102 0.8× 15 1.1k
Kurt Sowers United States 6 472 0.7× 122 0.5× 168 0.7× 129 0.6× 141 1.1× 6 681
Farzana Perwad United States 15 840 1.2× 261 1.1× 422 1.8× 386 1.8× 275 2.1× 26 1.1k
Silvia Lopez-Hilker United States 11 686 1.0× 298 1.2× 187 0.8× 424 2.0× 99 0.7× 15 981
Hillel Galitzer Israel 7 894 1.3× 253 1.1× 534 2.3× 264 1.3× 274 2.0× 11 1.0k
Kyoko Nagasue Japan 10 464 0.7× 106 0.4× 144 0.6× 119 0.6× 79 0.6× 11 621

Countries citing papers authored by Tomoko Nii‐Kono

Since Specialization
Citations

This map shows the geographic impact of Tomoko Nii‐Kono's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomoko Nii‐Kono with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomoko Nii‐Kono more than expected).

Fields of papers citing papers by Tomoko Nii‐Kono

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomoko Nii‐Kono. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomoko Nii‐Kono. The network helps show where Tomoko Nii‐Kono may publish in the future.

Co-authorship network of co-authors of Tomoko Nii‐Kono

This figure shows the co-authorship network connecting the top 25 collaborators of Tomoko Nii‐Kono. A scholar is included among the top collaborators of Tomoko Nii‐Kono based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomoko Nii‐Kono. Tomoko Nii‐Kono is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Abe, Takaya, Hirotaka Komaba, Hideki Fujii, et al.. (2008). Serum Pro‐hepcidin as an Indicator of Iron Status in Dialysis Patients. Therapeutic Apheresis and Dialysis. 12(3). 226–231. 9 indexed citations
2.
Hamada, Yasuhiro, Satoshi Miyata, Tomoko Nii‐Kono, et al.. (2007). Overexpression of thioredoxin1 in transgenic mice suppresses development of diabetic nephropathy. Nephrology Dialysis Transplantation. 22(6). 1547–1557. 38 indexed citations
3.
Nii‐Kono, Tomoko, Yuzuru Iwasaki, M. Uchida, et al.. (2007). Indoxyl sulfate induces skeletal resistance to parathyroid hormone in cultured osteoblastic cells. Kidney International. 71(8). 738–743. 152 indexed citations
4.
Shiizaki, Kazuhiro, Masafumi Fukagawa, Ikuji Hatamura, et al.. (2007). Direct Injection of Calcitriol or Its Analog Improves Abnormal Gene Expression in the Hyperplastic Parathyroid Gland in Uremia. American Journal of Nephrology. 28(1). 59–66. 4 indexed citations
5.
Iwasaki, Yoshiko, Hideyuki Yamato, Tomoko Nii‐Kono, et al.. (2006). Administration of oral charcoal adsorbent (AST-120) suppresses low-turnover bone progression in uraemic rats. Nephrology Dialysis Transplantation. 21(10). 2768–2774. 63 indexed citations
6.
Iwasaki, Yuzuru, Hideyuki Yamato, Tomoko Nii‐Kono, et al.. (2006). Insufficiency of PTH action on bone in uremia. Kidney International. 70(102). S34–S36. 32 indexed citations
7.
Iwasaki, Yoshiko, Hideyuki Yamato, Tomoko Nii‐Kono, et al.. (2006). Uremic toxin and bone metabolism. Journal of Bone and Mineral Metabolism. 24(2). 172–175. 19 indexed citations
8.
Nakanishi, Shohei, Junichiro James Kazama, Tomoko Nii‐Kono, et al.. (2005). Serum fibroblast growth factor-23 levels predict the future refractory hyperparathyroidism in dialysis patients. Kidney International. 67(3). 1171–1178. 160 indexed citations
9.
Fukagawa, Masafumi, Tomoko Nii‐Kono, & Junichiro James Kazama. (2005). Role of fibroblast growth factor 23 in health and in chronic kidney disease. Current Opinion in Nephrology & Hypertension. 14(4). 325–329. 43 indexed citations
10.
Koiwa, Fumihiko, Junichiro James Kazama, Noritaka Onoda, et al.. (2005). Sevelamer Hydrochloride and Calcium Bicarbonate Reduce Serum Fibroblast Growth Factor 23 Levels in Dialysis Patients. Therapeutic Apheresis and Dialysis. 9(4). 336–339. 111 indexed citations
11.
12.
Nishi, Hiroshi, Tomoko Nii‐Kono, Shohei Nakanishi, et al.. (2005). Intravenous Calcitriol Therapy Increases Serum Concentrations of Fibroblast Growth Factor-23 in Dialysis Patients with Secondary Hyperparathyroidism. Nephron Clinical Practice. 101(2). c94–c99. 103 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fabiana G. Graciolli Breakdown of academic impact, for papers by Laura C. McCary Breakdown of academic impact, for papers by Arnold J. Felsenfeld Breakdown of academic impact, for papers by Pablo Román‐García Breakdown of academic impact, for papers by Kátia R. Neves Breakdown of academic impact, for papers by Kurt Sowers Breakdown of academic impact, for papers by Farzana Perwad Breakdown of academic impact, for papers by Silvia Lopez-Hilker Breakdown of academic impact, for papers by Hillel Galitzer Breakdown of academic impact, for papers by Kyoko Nagasue
Rankless by CCL
2026